Showing posts with label Humira Crohn's Disease. Show all posts
Showing posts with label Humira Crohn's Disease. Show all posts

Tuesday, June 24, 2014

Humira Crohn's Disease

Humira Crohn's Disease
Humira (adalimumab) is a human monoclonal antibody that functions by blocking the Tumor Necrosis Factor alpha (TNF-alpha), a very active cytokine that is responsible for the inflammatory process. Individuals suffering from Crohn's disease have exhibited an abnormal amount of the TNF-alpha; hence Humira will stop it from being used by the body.



Humira, which comes in the form of an injection, contains the active ingredient adalimumab, a kind of medicine known as human monoclonal antibody. This functions by suppressing part of the human's immune system hence modifying the inflammation process. The Humira Crohn's disease injection is given beneath the skin either at home or by a doctor in a hospital.



Humira Crohn's disease is normally prescribed when all other Crohn's medications have failed to work, or if the symptoms of the disease become overly severe. It is injected either weekly or once every other week, with a dosage of 40mgs. Note that the location where the drug is injected should not be repeated twice in a row i.e. patients ought to rotate where they inject Humira - mostly on the front of either thigh or the abdomen.



Successful effect of Humira for Crohn's disease is that it substantially reduces the symptoms of the disease i.e. diarrhea, fatigue, and pain, and sometimes may induce remission. The most common side effects of this injection are irritation, pain, itching or swelling at the location of injection. Nausea, rash, and headache are other common Humira side effects.



Be advised that there is a high chance of developing serious infections when using Humira. Infections such as TB, as well as bacterial, fungal, or viral infections which have already spread through the body are just few of the many examples. Developing some adverse side effects like allergic reactions, some form of cancer, nervous system problems, hepatitis B reactivation, some immune reactions, heart failure, and blood problems are other examples of the side effects of using Humira for Crohn's disease.



As such, it is highly recommended that Humira is used only as a prescription drug, and even in that case, it should not be taken with any other TNF-blocking agent like methotrexate, live vaccines, or kineret (anakinra). Discuss with your doctor if you are taking any type of medication that is known to suppress the immune system. But by and large, in Crohn's disease treatment, Humira considerably reduces the movement of inflammatory cells to the inflamed parts of the intestines.